• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 30th August 2018

OHE Awarded Research Grant to Evaluate PSS CQUIN Interventions

OHE together with York, Manchester and Imperial have been awarded a grant from the NIHR PRP to evaluate the PSS Commissioning for Quality and Innovation (CQUIN) schemes. OHE, together with the universities of York, Manchester and Imperial College London, has…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

OHE together with York, Manchester and Imperial have been awarded a grant from the NIHR PRP to evaluate the PSS Commissioning for Quality and Innovation (CQUIN) schemes.

OHE, together with the universities of York, Manchester and Imperial College London, has been awarded a grant from the National Institute for Health Research (NIHR) to evaluate the Prescribed Specialised Services (PSS) Commissioning for Quality and Innovation (CQUIN) schemes.

During the last 15 years, financial incentives have been widely introduced into the English National Health Services (NHS) as an instrument to promote quality health care by linking monetary incentives to the performance of health care providers. The empirical evidence on the effectiveness of introducing incentive schemes associated with health policy under the English NHS is mixed, and questions remain unanswered regarding the impact of the design of financial incentives on programme effectiveness.

In April 2013, NHS England became responsible for commissioning 143 specialised services and managing its budget. In general terms, specialised services in England refer to services that are provided by relatively few hospitals to support people with a range of rare and complex conditions. The budget for specialised services in England for the financial year 2017/18 is around £16.6 billion. 

The Prescribed Specialised Services (PSS) Commissioning for Quality and Innovation (CQUIN) schemes were introduced by NHS England. Each scheme links an incentive payment to a hospital provider’s performance for improving the quality of specialised services. In 2017/18, PSS CQUIN schemes include seven national programmes covering a total of 24 schemes. NHS England intends to allocate £900 million to this programme between April 2016 and March 2019. It is therefore important for policymakers to understand the effectiveness and efficiency of this significant investment.

OHE, in collaboration with Imperial College London, the University of Manchester, and the University of York, have been awarded research funding from the NIHR Policy Research Programme (PRP) to conduct an evaluation of the Effectiveness and Value for Money of Prescribed Specialised Services Commissioning for Quality and Innovation (CQUIN) interventions 2016/17 to 2018/19. This two-year project will evaluate 10-12 selected PSS CQUIN schemes. Findings from this study will be used to inform contracting decisions for 2019/20 and future rounds of contracting of specialised services and will contribute to a wider knowledge-base on optimal contract design in secondary care.

This study aims to address the following five research questions:

  1. How effectively do the PSS CQUIN schemes improve the quality of hospital services for specialised care in the English NHS?
  2. Are specific interventions supported by different PSS CQUIN schemes cost effective?
  3. What lessons can be learned from the ongoing PSS CQUIN schemes to inform NHS England in their preparations for contracting from April 2019?
  4. Should specific quality innovations under the PSS CQUIN schemes be supported in future contracting rounds and, if so, how?
  5. What lessons can be learned from this study to develop optimal contract designs for quality incentives in the NHS?

The project adopts a mixed methods approach including quantitative and qualitative analysis. For the quantitative aspect of the study, the team will conduct econometric analyses to evaluate the effectiveness and cost-effectiveness of the selected schemes. For the qualitative aspect of the study, the team will conduct semi-structured interviews and focus groups with NHS commissioners, healthcare providers, and finance leads to identify factors affecting a scheme’s uptake, challenges and barriers for implementation, and complexities underlying the contracting/delivery process.   

The project is led by Yan Feng at OHE (Principal Investigator). The project team includes Paula Lorgelly and Marina Rodes Sanchez from OHE, Søren Rud Kristensen from Imperial College London, Matt Sutton and Rachel Meacock from the University of Manchester, and Luigi Siciliani from the University of York.

The project is funded by NIHR Policy Research Programme (Reference number: PR-R18-0117-22001). The views expressed in this blog post are those of the author and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

For further information, please contact Yan Feng.

Related research

Feng, Y., Ma, A., Farrar, S. and Sutton, M., 2015. The tougher the better: an economic analysis of increased payment thresholds on the performance of general practice. Health Economics, 24(3), pp.353-371. DOI | RePEc

Karlsberg Schaffer, S., Sussex, J. and Feng, Y., 2015. Incentives to Follow Best Practice in Health Care. OHE Briefing. RePEc

Maynard, A., 2014. Contracting for Quality in the NHS. OHE Monographs. RePEc

  • Healthcare Systems
  • Policy, Organisation and…
  • Grants

Related News

  • News
  • December 2019

New OHE Research Funding: Improving Labour Productivity in Primary Care

Read more
  • News
  • October 2019

Making Outcome-based Payment a Reality in the NHS: Moving to the Next Phase

Read more
  • News
  • May 2019

OHE is Leading Research to Develop EQ-5D ‘Bolt-ons’ for Cognition and Vision

Read more
  • News
  • September 2018

UKRI Funds OHE Collaboration in Student Mental Health Research Network

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!